Roche

Roche seeks FDA approval for Kadcyla in HER2-positive early breast cancer
Pharmaceutical Business Review
Tue, 02/5/19 - 10:18 am
Roche
FDA
Kadcyla
HER2-positive early breast cancer
Roche (RHHBY) 2018 Sales Up on Solid New Drugs Performance
Yahoo/Zacks.com
Sat, 02/2/19 - 12:24 pm
Roche
earnings
Report: five companies would take brunt of Trump Part B proposal
BioCentury
Fri, 02/1/19 - 11:24 am
Donald Trump
Medicare Part B
Amgen
Regeneron
Bristol-Myers Squibb
Genentech
Roche
All Eyes on Biogen as Roche Alzheimer’s Drug Flunks Final Test
Xconomy
Wed, 01/30/19 - 11:56 am
Roche
Alzheimer's disease
clinical trials
AC Immune
crenezumab
Biogen
aducanumab
FDA Gives Greenlight to Janssen and AbbVie's Imbruvica for the 10th Time
BioSpace
Mon, 01/28/19 - 12:11 pm
Imbruvica
Janssen
AbbVie
Roche
Gazyva
chronic lymphocytic leukemia
small lymphocytic lymphoma
FDA
Last week in biopharma - earnings reports, drug pricing, a new GENE CEO and more
CP Wire
Sun, 01/27/19 - 07:09 pm
earnings
drug pricing
Genentech
Eli Lilly
Medtronic
Roche
M&A
Takeda
GSK
FDA
Last week in biopharma-earnings reports, drug pricing, a new GENE CEO and more
Mon, 02/4/19 - 02:45 pm
earnings
drug pricing
Genentech
Eli Lilly
Medtronic
Roche
M&A
Takeda
GSK
FDA
Alexander Hardy tapped to head back to South San Francisco as the next CEO at Genentech
Endpoints
Thu, 01/24/19 - 11:50 am
Genentech
Roche
Alexander Hardy
Pharma CEOs
Basilea Enters Collaboration With Roche to Study BAL087 in Combination With Tecentriq in Urothelial Cancer
CP WIre
Thu, 01/24/19 - 11:43 am
Arqule
Basilea
Roche
BAL087
urothelial cancer
Tecentriq
Basilea Enters Collaboration With Roche to Study BAL087 in Combination With Tecentriq in Urothelial Cancer
Thu, 01/24/19 - 10:38 am
Arqule
Basilea
Roche
BAL087
urothelial cancer
Tecentriq
Roche says 'no thanks' to megadeals, but don't count out smaller M&A
Fierce Pharma
Tue, 01/22/19 - 11:50 am
Roche
M&A
Christoph Franz
FDA Approves 17th Biosimilar, Third for Herceptin
RAPS.org
Fri, 01/18/19 - 09:44 pm
FDA
Merck
Samsung Bioepis
Ontruzant
biosimilars
Roche
Herceptin
Phoenix, Roche partner to develop TNBC biomarker
BioCentury
Wed, 01/16/19 - 11:57 pm
Roche
Phoenix Molecular Designs
diagnostics
molecular diagnostics
triple negative breast cancer
biomarkers
NASH Space in Focus in 2019 as Firms Look to Diversify
Yahoo/Zacks.com
Sun, 01/13/19 - 11:32 am
NASH
Gilead Sciences
Merck
Roche
Novartis
Jecure Therapeutics
Pfizer
Celgene
Eli Lilly
Genentech Cutting More Jobs in Bay Area
BioSpace
Wed, 01/2/19 - 11:23 am
Genentech
Roche
layoffs
Bay Area
Down but Not Out: 10 Biggest Drug Trials That Saw Challenges in 2018
BioSpace
Fri, 12/21/18 - 12:10 pm
clinical trials
Takeda
Zinfandel Pharmaceuticals
pioglitazone
Alzheimer's disease
Boehringer Ingelheim
BI 409306
Merck
verubecestat
Celgene
MS
ozanimod
Incyte
ID01
melanoma
vTv Therapeutics
azeliragon
Roche
Tecentriq
Exelixis
colorectal cancer
JNJ
atabacestat
Sareptat Therapeutics
DMD
Exondys 51
Alkermes
ALKS-5461
clinical depression
Merck taps Roche for Keytruda companion diagnostic
Medtech Dive
Wed, 12/12/18 - 06:41 pm
Merck
Roche
solid tumors
oncology
biomarkers
companion diagnostics
diagnostics
Gilead Taps Roche Veteran Daniel O’Day as New CEO
BioSpace
Mon, 12/10/18 - 11:58 am
Gilead Sciences
Pharma CEOs
Roche
Daniel O'Day
China approves Descovy, Harvoni, Hemlibra
BioCentury
Tue, 12/4/18 - 11:51 pm
China
Harvoni
Descovy
Hemlibra
Roche
Gilead Sciences
One more shot at slowing Keytruda’s first-line lung cancer domination
EP Vantage
Wed, 11/28/18 - 10:12 am
Keytruda
Merck
Roche
Tecentriq
Avastin
lung cancer

Pages